Valproate Sodium for Injection
Manufacturer:
West-Ward
Indications:
Valproate sodium indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. Valproate sodium injection is also indicated for use as sole and adjunctive therapy in the treatment of patients with simple and complex absence seizures, and adjunctively in patients with multiple seizure types that include absence seizures. For indications, dosing and other information, please refer to the manufacture package insert.
|
| |
| Product |
Size |
NDC Numbers |
PI |
MSDS |
|
Valproate Sodium |
100mg/mL 5mL |
00143-9785-10 |
PI |
MSDS |
| |
|
| Clinical Data:
For any questions or for
further information regarding
Valproate Sodium Injection, clinical pharmacology, additional indications and
usages, contraindications,
warnings, precautions, adverse
reactions, dosage,
administration and/or storage
of this product, please
contact
BDI Pharma or call
1-800-948-9834. |
| |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|